Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1990-05-18
1994-02-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 514568, 514916, 514947, 514960, 514962, 514966, A61K 3119
Patent
active
052867510
ABSTRACT:
Sustained and enhanced antipyretic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering from elevated body temperature (fever), by administering thereto a unit dosage sustainedly enhancing, antipyretically effective amount of the free acid S(+) flurbiprofen enantiomer, said enantiomer being substantially free of its R(-) flurbiprofen antipode.
REFERENCES:
patent: 3637767 (1972-01-01), Alvarez
patent: 3755427 (1973-08-01), Adams et al.
patent: 4440787 (1984-04-01), de Vincentiis
patent: 4486436 (1984-12-01), Sunshine et al.
patent: 4501727 (1985-02-01), Armitage et al.
patent: 4542237 (1985-09-01), Schloemer
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4567183 (1986-01-01), Sunshine et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 4722938 (1988-02-01), Sunshine et al.
patent: 4871733 (1989-10-01), Sunshine et al.
patent: 4927854 (1990-05-01), Sunshine et al.
(1) Hutt et al., "The Importance of Stereochemistry in the Clinical Pharmacokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory Drugs" Clinical Pharmacokinetics 9:371-373 (1984).
(2) Hutt et al., "The metabolic chiral inversion of 2-arylpropionic acids-a novel route with pharmacological consequences", J. Pharm. Pharmacol. 35:693-704 (1983).
(3) Kaiser et al., "Isomeric Inversion of Ibuprofen (R)-Enantiomer in Human" Journal of Pharmaceutical Sciences, vol. 65, No. 2 (1976).
(4) Snyder et al., "Intradermal Anti-Prostaglandin Agents and Sunburn" The Journal of Investigative Dermatology, 62:47-50 (1974).
(5) Snyder et al., "Topical indomethacin and sunburn", British Journal of Dermatology, 90-91 (1974).
(6) Edwards et al., "Reduction of Erythema Response to Ultraviolet Light by Nonsteroidal Antiinflammatory Agents", Arch Dermatol Res, 272:263-267 (1982).
(7) Gomez et al., "Effect of Topical Diflumidone on Ultraviolet-Light-Induced Erythema", Dermatologica 162:175-182 (1981).
(8) Greenbert et al., "Orally Given Indomethacin and Blood Flow Response to UVL", Arch Dermatol, vol. 111, 328-330 (1975).
(9) Lim et al., "Effect of Indomethacin on Alteration of ATPase-Positive Langerhans Cell Density and Cutaneous Sunburn Reaction Induced by Ultraviolet-B Radiation", Journal of Investigative Dermatology, 81:455-468 (1983).
(10) Flowers et al., "A Comparative Study of the Effect of Flurbiprofen and Indomethacin on Sunburn", Current Therapeutic Research, vol. 36, No. 4, 787-791 (1984).
(11) Tan et al., "Effect of Topically Applied Flurbiprofen on Ultraviolet-Induced Erythema", Drug Intelligence and Clinal Pharmacy, vol. 20, 496-499 (1986).
(12) Allison et al., "Naproxen", Anti-Inflammatory and Anti-Rheumatic Drugs, vol. II, 171-188 (1985).
(13) Doyle et al., Abstract No. 85-42694, "The Resolution of Enantiomeric Drugs Using HPLC Chiral Stationary Phases", Pharm Technol (9, No. 2, 28-32) (1985).
(14) Wainer et al., Abstract No. 84-29713, "Application of High-Performance Liquid Chromatographic Chiral Stationary Phases to Pharmaceutical Analysis: Structural and Conformational Effects in the Direct Enantiomeric Resolution of Alpha Methylarylacetic Acid Antiinflammatory Agent", J. Chromatogr (284, No. 1, 117-124) (1984).
(15) Sallustio et al., Abstract No. 86-28516, "Enantiospecific High-Performance Liquid Chromatographic Analysis of 2-Phenylpropionic Acid, Ketoprofen and Fenoprofen", J. Chromatogr. Biomed. Appl., (374, No. 2, 329-337) (1986).
(16) Singh et al., Abstract No. 86-46614, "Gas Chromatographic Separation of Optically Active Anti-Inflammatory 2-Arylpropionic Acids Using (+)-or (-)-Amphetamine as Derivatizing Reagent", J. Chromatogr. Biomed. Appl., (378, No. 1, 125-135) (1986).
Laska Eugene M.
Sunshine Abraham
Analgesic Associates
Waddell Frederick E.
Weddington K.
LandOfFree
Sustained/enhanced antipyretic response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained/enhanced antipyretic response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained/enhanced antipyretic response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207283